Announcements Trials
Browse Landscape

Status

Unknown 7Recruiting 7Completed 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Invasive Aspergillosis 1Head and Neck Neoplasms 1Colonic Neoplasms 1Chronic Disease 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Registries × Clear all
NCT03221075 2023-05-12

CLARITY

University Hospital of Cologne

Completed
203 enrolled

Invasive Aspergillosis

NCT03546322 2022-07-01

Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers

University of California, San Francisco

Completed
802 enrolled
Head & Neck

Chronic Disease, Head and Neck Neoplasms

NCT01310972 2018-08-10

Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX

King Faisal Specialist Hospital & Research Center

Completed
6 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡